Comment on

• Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

  André MPE, Girinsky T, Federico M, Reman O, Fortpied C, Gotti M, Casasnovas O, Brice P, van der Maazen R, Re A, Edeline V, Fermé C, van Imhoff G, Merli F, Bouabdallah R, Sebban C, Specht L, Stamatoullas A, Delarue R, Fiaccadori V, Bellei M, Raveloarivahy T, Versari A, Hutchings M, Meignan M, Raemaekers J. André MPE, et al. J Clin Oncol. 2017 Jun 1;35(16):1786-1794. doi: 10.1200/JCO.2016.68.6394. Epub 2017 Mar 14. J Clin Oncol. 2017. PMID: 28291393 Clinical Trial.
• Interim Fluorodeoxyglucose Positron Emission Tomography-Adapted Therapy Is Not an Efficient Approach to Improving Outcome in Early-Stage Hodgkin Lymphoma.

  Adams HJA, Kwee TC. Adams HJA, et al. J Clin Oncol. 2017 Aug 20;35(24):2850-2851. doi: 10.1200/JCO.2017.73.3816. Epub 2017 Jul 6. J Clin Oncol. 2017. PMID: 28682684 No abstract available.
• Striking a Happy Medium.

  Kothari S, Hernandez-Ilizaliturri F, Torka P. Kothari S, et al. J Clin Oncol. 2017 Aug 20;35(24):2852. doi: 10.1200/JCO.2017.73.9839. Epub 2017 Jul 6. J Clin Oncol. 2017. PMID: 28682685 No abstract available.
• On the Role of Interim Fluorine-18-Labeled Fluorodeoxyglucose Positron Emission Tomography in Early-Stage Favorable Hodgkin Lymphoma.

  Hindié E, Mesguich C, Zanotti-Fregonara P. Hindié E, et al. J Clin Oncol. 2017 Aug 20;35(24):2851-2852. doi: 10.1200/JCO.2017.73.8369. Epub 2017 Jul 6. J Clin Oncol. 2017. PMID: 28682690 No abstract available.
• Treatment of Early-Stage Hodgkin Lymphoma: Are We Just Shifting Morbidities?

  Vargo JA, Ling DC, Beriwal S. Vargo JA, et al. J Clin Oncol. 2017 Aug 20;35(24):2849-2850. doi: 10.1200/JCO.2017.73.3568. Epub 2017 Jul 6. J Clin Oncol. 2017. PMID: 28682691 No abstract available.